Nucryst Pharmaceuticals Corp. (NCST, NCS.TO) reported net income of $0.5 million or $0.03 per share for the third quarter, compared to a net loss of $0.1 million or $0.00 per share in the year-ago quarter.
Revenue for the third quarter increased to $6.1 million from $5.3 million in the prior year quarter.
For comments and feedback: editorial@rttnews.com